References
- Vermeir M, Lachau-Durand S, Mannens G. (2009). Absorption, metabolism, and excretion of darunavir: a new protease inhibitor administered alone and with low-dose ritonavir in healthy subjects. Drug Metab Dispos 37:809–20
- Charman WN, Stella VJ. (1991). Transport of lipophilic molecules by the intestinal lymphatic system. Adv Drug Deliv Rev 7:1–14
- Reddy LH, Murthy RSR. (2002). Lymphatic transport of orally administered drug. Indian J Exp Biol 40:1097–109
- Lachman L, Lieberman HA. (2009). The theory and practice of industrial pharmacy. New Delhi, India: CBS Publishers and Distributors, 313–17
- Goyal S, Vashist H. (2011). Development of alginate gel beads-entrapped liposome for colon specific drug delivery of prednisolone. Der Pharm Sin 2:31–8
- Sahay G, Alakhova D, Kabanov A. (2010). Endocytosis of nanomedicines. J Control Release 145:182–95
- Roger E, Lagarce F, Garcion E, Benoit JP. (2010). Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (London) 5:287–306
- Lind M, Jacobsen J, Holm R, Müllertz A. (2008). Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80. Eur J Pharm Sci 35:211–18
- Dahan A, Hoffman A. (2005). Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci 24:381–8
- Gao F, Zhang Z, Bu H, et al. (2011). Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism. J Control Release 149:168–74
- Zhang Z, Gao F, Bu H, et al. (2012). Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats. Nanomedicine 8:740–7
- Wasan K, Boyd M. (2004). A stepwise surgical procedure to investigate the lymphatic transport of lipid-based oral drug formulations: cannulation of the mesenteric and thoracic lymph ducts within the rat. J Pharmacol Toxicol 49:115–20
- Jani P, Halbert GW, Langridge J, Florence AT. (1989). The uptake and translocation of latex nanospheres and microis spheres after oral administration to rats. J Pharm Pharmacol 41:809–12
- Khan AA, Mudassir J. (2013). Advanced drug delivery to the lymphatic system: lipid based nanoformulations. Int J Nanomed 8:2733–44